Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03827161 · ClinicalTrials.gov registry record · Phase 1
Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients
A Phase 1 study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT03827161 is a Phase 1 study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 2 participants.
The verdict
NCT03827161, a Phase 1 study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This trial studies glucosamine and chondroitin in preventing inflammation in overweight patients. Chronic inflammation contributes to cancer formation, and biomarkers of inflammation have been associated with cancer risk. Glucosamine and chondroitin may prevent inflammation and this trial may help identify the bacteria that help process them in the gut.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Glucosamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2017-08-01 |
| Est. Completion | 2018-12-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03827161
The ClinicalTrials.gov registry entry for NCT03827161 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03827161 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03827161 about?
NCT03827161 is a clinical study titled "Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients". This trial studies glucosamine and chondroitin in preventing inflammation in overweight patients. Chronic inflammation contributes to cancer formation, and biomarkers of inflammation have been associated with cancer risk. Glucosamine and chondroitin may prevent inflammation and this trial may help i...
What is the current status of trial NCT03827161?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2017-08-01. Estimated completion is 2018-12-01.
What interventions are being tested in trial NCT03827161?
The interventions under investigation include: Placebo (OTHER), Glucosamine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03827161?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.